BioCatalyst

HS-20093, Topotecan — catalyst calendar

1 verified catalyst event(s) referencing HS-20093, Topotecan, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-30
in 2mo
ESTIMATED
 READOUT
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cel
Phase 3 · Small Cell Lung Cancer
 Hansoh BioMedical R&D Company HS-20093, Topotecan ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.